Capricor Therapeutics, Inc.
CAPR
Health Care
2
exclusion reasons
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Capricor Therapeutics is a biotechnology company whose primary product candidates are derived from human cells. However, its development pipeline includes therapies for Duchenne muscular dystrophy (DMD) and other conditions that have historically required extensive animal testing for regulatory approval. The company's stated policy to "develop and supply pharmaceuticals that are safe and highly effective" implies a reliance on preclinical animal models to meet FDA requirements for safety and efficacy data, a standard industry practice for drug development. As a clinical-stage biopharmaceutical company, its research and development activities are built on a foundation of animal experimentation.
Capricor Therapeutics is a clinical-stage biotechnology company focused on developing cell and exosome-based therapeutics. Its primary product candidates, including treatments for Duchenne muscular dystrophy and other cardiac conditions, require extensive preclinical animal studies as part of the regulatory pathway toward FDA approval. The company's public filings explicitly state that its drug development process "requires significant research and animal testing, which are referred to as preclinical studies." This animal testing is a non-negotiable component of the company's core business model and its applications for biologics licensure.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.